Cargando…
SARS-CoV-2 seroprevalence in Spain – Authors' reply
Autores principales: | Pollán, Marina, Pérez-Gómez, Beatriz, Pastor-Barriuso, Roberto, Oteo, Jesús, Pérez-Olmeda, Mayte, Yotti, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832783/ https://www.ncbi.nlm.nih.gov/pubmed/33160561 http://dx.doi.org/10.1016/S0140-6736(20)32266-2 |
Ejemplares similares
-
Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain()
por: Pérez-Olmeda, Mayte, et al.
Publicado: (2022) -
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
por: Pollán, Marina, et al.
Publicado: (2020) -
ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19
por: Pérez-Gómez, Beatriz, et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020) -
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)